Question 1039 — pharmacy and medications

Summary

Mrs. Michèle Peyron draws the attention of the Minister of Solidarity and Health to the adverse effects of the new formula of the drug Levothyrox in the treatment of the thyroid. Indeed, this medication aims to correct hypothyroidism linked to insufficient secretion of the thyroid gland or its absence, or to slow down the secretion of TSH; a hormone that stimulates the thyroid. It is the most prescribed medicine for the treatment of thyroid patients, around 3 million people in France, 80% of whom are women. Since the modification of the formula, patients have reported the existence of undesirable effects most certainly due to this medication, dizziness, headaches. In view of the wide distribution of this drug, she asks him what measures will be taken to reassure patients and that the new formula of the drug be modified.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.